Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer

K Sonkar, V Ayyappan, CM Tressler… - NMR in …, 2019 - Wiley Online Library
Activated choline metabolism is a hallmark of carcinogenesis and tumor progression, which
leads to elevated levels of phosphocholine and glycerophosphocholine in all types of …

[HTML][HTML] Phospholipase A2 Drives Tumorigenesis and Cancer Aggressiveness through Its Interaction with Annexin A1

L Vecchi, TG Araujo, FVPV Azevedo, STS Mota… - Cells, 2021 - mdpi.com
Phospholipids are suggested to drive tumorigenesis through their essential role in
inflammation. Phospholipase A2 (PLA2) is a phospholipid metabolizing enzyme that …

Nanoaggregate probe for breast cancer metastasis through multispectral optoacoustic tomography and aggregation‐induced NIR‐I/II fluorescence imaging

J Ouyang, L Sun, Z Zeng, C Zeng, F Zeng… - Angewandte …, 2020 - Wiley Online Library
An activatable nanoprobe for imaging breast cancer metastases through near infrared‐I
(NIR‐I)/NIR‐II fluorescence imaging and multispectral optoacoustic tomography (MSOT) …

[HTML][HTML] Annexin10 promotes extrahepatic cholangiocarcinoma metastasis by facilitating EMT via PLA2G4A/PGE2/STAT3 pathway

R Sun, Z Liu, B Qiu, T Chen, Z Li, X Zhang, Y Xu… - …, 2019 - thelancet.com
Background Cholangiocarcinoma (CCA), consisting of intrahepatic (IHCCA), perihilar
(PHCCA), and distal (DCCA) CCA, is a type of highly aggressive malignancy with a very …

[HTML][HTML] Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer

Y Fan, X Zhou, TS Xia, Z Chen, J Li, Q Liu, RN Alolga… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Purpose This work aims to identify differential metabolites and predicting molecular
subtypes of breast cancer (BC). Methods Plasma samples were collected from 96 BC …

FADS2 function at the major cancer hotspot 11q13 locus alters fatty acid metabolism in cancer

KSD Kothapalli, HG Park, NSL Kothapalli… - Progress in Lipid …, 2023 - Elsevier
Dysregulation of fatty acid metabolism and de novo lipogenesis is a key driver of several
cancer types through highly unsaturated fatty acid (HUFA) signaling precursors such as …

[HTML][HTML] BAG3 overexpression and cytoprotective autophagy mediate apoptosis resistance in chemoresistant breast cancer cells

CK Das, B Linder, F Bonn, F Rothweiler, I Dikic… - Neoplasia, 2018 - Elsevier
Target-specific treatment modalities are currently not available for triple-negative breast
cancer (TNBC), and acquired chemotherapy resistance is a primary obstacle for the …

[HTML][HTML] Human plasma metabolomics for biomarker discovery: Targeting the molecular subtypes in breast cancer

L Díaz-Beltrán, C González-Olmedo, N Luque-Caro… - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer is the leading cause of female cancer-related deaths
worldwide. New technologies with enhanced sensitivity and specificity for early diagnosis …

Phospholipase A2 inhibitors for the treatment of inflammatory diseases: a patent review (2010 – present)

V Magrioti, G Kokotos - Expert Opinion on Therapeutic Patents, 2013 - Taylor & Francis
Introduction: Phospholipases A2 have been implicated in various pathological conditions,
such as rheumatoid arthritis, cardiovascular diseases, neurological disorders and cancer …

EGFR TKI resistance in lung cancer cells using RNA sequencing and analytical bioinformatics tools

MC Howell Jr, R Green, J Cianne… - Journal of …, 2023 - Taylor & Francis
Abstract Epidermal Growth Factor Receptor (EGFR) signaling and EGFR mutations play key
roles in cancer pathogenesis, particularly in the development of drug resistance. For the∼ …